Algert Global’s Praxis Precision Medicines PRAX Stock Holding History

Algert Global’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.85M	Buy	17,478 +1,310	+8%	+$415K	0.07%	464
2026 Q1	$5.21M	Sell	16,168 -64,472	-80%	-$19.9M	0.08%	430
2025 Q4	$23.8M	Sell	80,640 -80,178	-50%	-$14.9M	0.37%	35
2025 Q3	$8.52M	Buy	160,818 +133,248	+483%	+$6.46M	0.14%	233
2025 Q2	$1.16M	Buy	27,570 +6,080	+28%	+$232K	0.02%	774
2025 Q1	$814K	Buy	+21,490	New	+$1.34M	0.02%	813
2023 Q2	–	Sell	-1,885	Closed	-$22.9K	–	1217
2023 Q1	$22.9K	Buy	1,885 +96	+5%	+$4.05K	﹤0.01%	1113
2022 Q4	$63.9K	Buy	+1,789	New	+$55.8K	﹤0.01%	1095

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Algert Global's PRAX Position: Q2 2026 in Review

Algert Global increased its Praxis Precision Medicines (PRAX) stake by 8.1% in Q2 2026, buying an estimated $415K and bringing the position to 17,478 shares worth $5.85M. The position accounts for 0.07% of the portfolio, ranked #464.

Algert Global first reported a position in PRAX in Q4 2022 and has held it in 8 quarters since. The position peaked at $23.8M in Q4 2025. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Algert Global held 17,478 shares of Praxis Precision Medicines worth $5.85M as of Q2 2026.
Algert Global bought 1,310 Praxis Precision Medicines shares in Q2 2026, an estimated $415K.
Praxis Precision Medicines made up 0.07% of Algert Global's portfolio in Q2 2026, its #464 holding.
Algert Global first reported a position in Praxis Precision Medicines in Q4 2022 and has held it in 8 quarters since.
Algert Global's Praxis Precision Medicines position peaked at $23.8M in Q4 2025.
310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.